Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
Clinical trial NCT05521438 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05521438
- Sponsor
- Quoin Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2025-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.